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ackground: Vitamin D insufficiency might be associated with biased T-cell responses resulting in
flammatory conditions such as atopy and asthma. Little is known about the role of vitamin D in low-grade
ystemic inflammation and airway hyperresponsiveness (AHR) in young children.
bjective: To evaluate whether vitamin D insufficiency and increased serum high-sensitivity C-reactive
protein (hs-CRP) are linked to AHR in symptomatic infants.
Methods: Seventy-nine infants with recurrent or persistent lower respiratory tract symptoms underwent
comprehensive lung function testing and a bronchial methacholine challenge test. In addition, skin prick
tests were performed and serum 25-hydroxyvitamin D (S-25-OHD), hs-CRP, total immunoglobulin E, and
blood eosinophil levels were determined.
Results: S-25-OHD was lowest in infants with blood eosinophilia and AHR (n ¼ 10) compared with those
with eosinophilia only (n ¼ 6) or AHR only (n ¼ 50) or those with neither (n ¼ 13; P ¼ .035). Moreover,
vitamin D insufficiency (S-25-OHD <50 nmol/L) was most common in infants with blood eosinophilia and
AHR (P ¼ .041). Serum hs-CRP was lower in infants with recurrent physician-diagnosed wheezing (P ¼ .048)
and in those with blood eosinophilia (P ¼ .015) than in infants without these characteristics and was not
associated with S-25-OHD or AHR. S-25-OHD levels were significantly lower (median 54 nmol/L) during the
autumn-winter season than in the spring-summer season (median 63 nmol/L; P ¼ .026).
Conclusion: Vitamin D insufficiency could underlie eosinophilia and AHR in infants with troublesome lung
symptoms, whereas hs-CRPemediated low-grade systemic inflammation is rare in early childhood wheezing.
 2017 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.Introduction In schoolchildren with asthma, serum hs-CRP was higher than inEvidence on the association between low serum vitamin D
concentrations and asthma is currently inconsistent.1 In children
with asthma, low vitamin D levels have been associated with
decreased lung function2 and airway hyperresponsiveness
(AHR),3,4 but there are contradictory results.1,5 In young wheezing
children, vitamin D insufficiency has been linked to exacerbations
requiring treatment with oral corticosteroids.6
High-sensitivity C-reactive protein (hs-CRP) is a biomarker
reflecting low-grade systemic inflammation. A recentmeta-analysis
suggested that vitamin D supplementation decreases serum hs-CRP
levels by 1 mg/L and that the effect is even more pronounced
in adults with baseline hs-CRP levels of at least 5 mg/L.7Hospital, PO Box 160/1, FI-00029
helsinki.fi.
rch, Research Foundation of the
ion, Sigrid Jusélius Foundation,
Foundation.
sthma & Immunology. Published by Eltheir healthy peers, and a similar finding emerged between symp-
tomatic steroid-free children and those who used inhaled cortico-
steroids.8 In schoolchildren with asthma, lung function correlated
negatively with serum hs-CRP,8 whereas in adolescents lung func-
tion,9 AHR,10 and serum vitamin D levels5 were not associated with
hs-CRP. Neonatal lung function and plasma hs-CRP measured at 6
months of age correlated inversely.11
Because vitamin D might decrease low-grade systemic inflam-
mation and protect young children from asthma, the aim of this
study was to assess the incidence of vitamin D insufficiency and hs-
CRPemediated systemic inflammation in infants with lower airway
symptoms and to determine whether vitamin D insufficiency and
increased serum hs-CRP might be linked to AHR in this population.
Methods
Patients
Seventy-nine consecutive infants with recurrent or persistent
lower respiratory tract symptoms who were referred to a tertiarysevier Inc. All rights reserved.
Table 1
Baseline Characteristics and Measurements in Study Infants
Baseline characteristicsa All infants (N ¼ 79)
Age (mo) 15 (12e20)
BMI (kg/m2) 17.0 (1.4)
Boys 55 (70)
History of physician-diagnosed wheezing (1 episode) 50 (63)
Atopic eczemab 34 (43)
Positive SPT reactionc 21 (27)
Atopyd 42 (53)
Total IgE (kU/L) 15 (8e40)
Blood eosinophil count (109/L) 0.25 (0.17e0.38)
Blood eosinophils (%) 3 (2e4)
Blood eosinophiliae 16 (20)
Lung function parameters
FRC z-score 1.0 (1.2)
FRC z-score 2 SD 18 (23)
V0max,FRC z-score 0.7 (1.0)
V0max,FRC z-score 2 SD 9 (11)
Methacholine challenge test
PD40 V0max,FRC (mg) 0.35 (0.19e0.80)
0.90 mg 60 (76)
S-25-OHD (nmol/L) 59 (49e71)
<50 nmol/L 20 (25)
hs-CRP (mg/L) 0.12 (0.02e0.62)
Abbreviations: BMI, body mass index; FRC, functional residual capacity; hs-CRP,
high-sensitivity C-reactive protein; IgE, immunoglobulin E; PD40 V0max,FRC, dose of
methacholine causing 40% decrease in maximal expiratory flow at functional re-
sidual capacity; S-25-OHD, serum 25-hydroxyvitamin D; SPT, skin prick test;
V0max,FRC, maximal expiratory flow at functional residual capacity.
aData are presented as mean (SD), median (interquartile range), or number
(percentage).
bDiagnosed by a pediatrician.
cA wheal of at least 3 mm compared with any of the tested allergens.
dAtopic eczema and/or positive SPT reaction.
ePeripheral blood eosinophil count of at least 0.4  109/L and percentage of at least
4% of total leukocytes.
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included in the present cross-sectional study. The study infants
were 6 to 27 months old (median 15 months, interquartile range
[IQR] 12e20 months) and underwent clinical examination, skin
prick tests (SPTs), and peripheral blood sampling to determine
blood eosinophil count and serum total immunoglobulin E (IgE),
25-hydroxyvitamin D (S-25-OHD), and hs-CRP. Comprehensive
lung function testing included whole body plethysmography,
measurements of tidal forced expirations with rapid thor-
acoabdominal compression, and a dosimetric bronchial meth-
acholine challenge test. The medical history of the patients was
charted by parental interviews using a structured questionnaire
and a prospective review of the medical records.
The research ethics committee of the local university hospital
approved the study. Written informed consent was obtained from
the parents or legal guardians of the study children before any tests
were performed or samples were drawn.
Lung Function Tests and Bronchial Methacholine Challenge Test
Lung function tests (eg, whole body plethysmography with
rapid thoracoabdominal compression) were conducted as previ-
ously documented.12 To summarize briefly, the functional residual
capacity (FRC) was determined with whole body plethysmog-
raphy,12 and the maximal flow at FRC (V0max,FRC) was determined
using the rapid thoracic compression technique,12 during which 3
acceptable maximal partial expiratory flow volume curves were
recorded to calculate the mean V0max,FRC. For the dosimetric bron-
chial methacholine challenge test,12 there were 2 end points in the
challenge: a decrease of at least 40% in V0max,FRC or reaching the
maximal dose of methacholine. The provocative dose of meth-
acholine causing a 40% decrease in V0max,FRC (PD40 V0max,FRC) was
determined from the dose-response curves.
Determining S-25-OHD and hs-CRP
Serum S-25-OHD was measured on an Abbott Architect ci8200
analyzer (Abbott Laboratories, Abbott Park, Illinois) in the labora-
tory of the Genomics and Biomarkers Unit at the National Institute
for Health and Welfare (Helsinki, Finland). The laboratory has been
accredited by the Finnish Accreditation Service and it fulfils the
requirements of the standards SFS-EN ISO/IEC 17025:2005. The
method is a high-throughput automated chemiluminescent
microparticle immunoassay (Architect 25-OH Vitamin D assay;
Abbott Laboratories), which measures 25-OH-D2 and 25-OH-D3.
For standardizing measurements, the laboratory has taken part in
the Vitamin D External Quality Assessment Scheme organized by
Imperial College Healthcare (National Health Service, London,
United Kingdom). The coefficient of variation of the method
(mean  SD) and systematic error (bias; mean  SD) were
3.6  1.5% and 6.5  7.0%, respectively. Serum samples for hs-CRP
determination by immunoturbidimetric assay (CRPHS; Roche
Diagnostics GmbH, Mannheim, Germany) were available from 63
infants. To minimalize the effect of a possible acute infection or
inflammation, infants with hs-CRP levels of at least 10 mg/L were
excluded,13 and hs-CRP results of the remaining 61 infants were
included in the final analyses.
Definitions
Persistence or recurrence of lower airway symptoms was
assessed in a parental interview using a structured questionnaire
by a trained pediatrician. Atopic eczema was defined as a current
diagnosis made by a pediatrician.12 SPT positivity was defined as a
wheal with a diameter of at least 3 mm against at least 1 of the
tested allergens.14 Blood eosinophilia was defined as an eosinophil
count of at least 0.4  109/L and eosinophils composing at least 4%
of leukocytes15 in peripheral blood. Atopy was defined as thepresence of atopic eczema and/or SPT positivity.12 Vitamin D
insufficiencywas defined as an S-25-OHD concentration lower than
50 nmol/L (ie,<20 ng/mL).16 In the methacholine challenge, a PD40
V0max,FRC no higher than 0.90 mg was defined as AHR to meth-
acholine and a value higher than 0.90 mg was defined as no or mild
responsiveness to methacholine.12 Increased hs-CRP was defined
by the 75th percentile (hs-CRP 0.62 mg/L).
Statistical Methods
A c2 test or Fisher exact test (if the expected frequency for any
cell was <5) was used for group comparisons of dichotomous
variables. Mann-Whitney U test or Kruskal-Wallis test was used to
analyze continuous or ordinal variables, respectively. Correlations
were determined using Spearman rank correlation test or Kendall s
statistics. Two-tailed tests were used in all analyses. A P value less
than .05 was considered statistically significant. The data were
analyzed IBM SPSS Statistics 22 for Windows (IBM Corp, Armonk,
New York).
Results
The baseline characteristics of the study infants included de-
mographics, laboratory measurements related to atopy, and lung
function parameters (Table 1). S-25-OHD levels varied from 27 to
121 nmol/L and were insufficient (<50 nmol/L) in 25% of infants
and sufficient in 75% of infants.
S-25-OHD levels, vitamin D insufficiency, and increased hs-CRP
levels (defined by the 75th percentile) were not associated with
AHR to methacholine (PD40 V0max,FRC 0.90 mg in bronchial
methacholine challenge test) in infants with recurrent or persistent
respiratory symptoms. In infants with AHR (n ¼ 60), the median
S-25-OHD level was 58 nmol/L (IQR 52e75 nmol/L), and in those
Figure 2. Vitamin D insufficiency (25-hydroxyvitamin D <50 nmol/L) was most
common in symptomatic infants with blood eosinophilia (EOSþ) and airway
hyperresponsiveness (AHRþ) compared with others.
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(IQR 51e76 nmol/L; P¼ .226). Vitamin D insufficiency was detected
in 17 infants (28%) with AHR and 3 infants (16%) without AHR
(P ¼ .371). Increased hs-CRP was detected in 12 infants (26%) with
AHR and 12 infants (80%) without AHR (P ¼ .742).
Similarly, vitamin D insufficiency was not associated with the
presence of respiratory symptoms or baseline lung function (data
not shown). The infants with blood eosinophilia (eosinophil count
0.4  109/L and eosinophils composing 4% of leukocytes) and
with documented AHR had significantly lower S-25-OHD levels
than those without these characteristics (Fig 1). Moreover, vitamin
D insufficiency was most common in this subgroup (Fig 2).
Serum hs-CRPwas lower in infants with recurrent (3 episodes)
physician-diagnosed wheezing (median 0.02 mg/L, IQR 0.02e0.12
mg/L, n ¼ 9) than in those without (median 0.16 mg/L, IQR
0.05e0.63 mg/L, n ¼ 51; P ¼ .048). Similarly, hs-CRP was lower in
those infants with blood eosinophilia (median 0.06 mg/L, IQR
0.02e0.11 mg/L, n ¼ 13) than in those without (median 0.18 mg/L,
IQR 0.05e0.74 mg/L, n ¼ 48; P ¼ .015). Neither S-25-OHD nor
hs-CRP correlated with age, body mass index, IgE, blood eosinophil
count or percentage, baseline lung function, AHR (Table 2), or each
other (sB ¼ 0.080, P ¼ .382), and they were not associated with sex,
atopic eczema, or SPT positivity (data not shown).
S-25-OHD concentration was significantly lower (median 54
nmol/L, range 27e106 nmol/L) during the autumn-winter season
(October toMarch) than during the spring-summer season (April to
September; median 63 nmol/L, range 45e121 nmol/L; P ¼ .026).
There was no such seasonal variation in hs-CRP (data not shown).
When stratifying the analyses by the season of the year, a
negative correlation emerged between S-25-OHD concentration
and blood eosinophil percentage (rs ¼ 0.348, P ¼ .015) in the
samples obtained during the autumn-winter season. Similarly, in
samples obtained during the autumn-winter season, vitamin D
insufficiency was much more prevalent in infants with blood
eosinophilia and AHR (n¼ 5 of 6, 83%) than in other infants (n¼ 12
of 42, 29%; P ¼ .017).
Discussion
Although in Finland the use of vitamin D supplementation is
advised for all children throughout the year, vitamin D insufficiency
was common in infants with troublesome lung symptoms, partic-
ularly in those with blood eosinophilia and AHR. In contrast,
increased hs-CRP levels were rare in wheezy infants and were not
associated with vitamin D status, blood eosinophilia, or AHR.Figure 1. Serum 25-hydroxyvitamin D concentration (median indicated with
horizontal line) was lowest in symptomatic infants with blood eosinophilia (EOSþ)
and airway hyperresponsiveness (AHRþ) compared with others.Consistent with a previous report from Finland,17 vitamin D
insufficiency was observed in one fourth of infants with recurrent
or persistent respiratory symptoms and was associated with the
dark and cold half of the year. The inverse association between S-
25-OHD level and age might indicate that the use of vitamin D
supplementation becomes more irregular as the children grow
older.17
Although the role of vitamin D in asthma is not fully established,
vitamin D insufficiency has been linked with worse asthma control,
more exacerbations, and emergency department visits in adults1
and children with asthma.1,6,18 In recurrent preschool wheezers,
vitamin D insufficiency has been associated with frequent exacer-
bations requiring oral corticosteroids,6 and oral supplementation of
vitamin D might lessen exacerbations during treatment of lower
airway symptoms with inhaled corticosteroids.19 In adults and
children with asthma, vitamin D levels and vitamin D insufficiency
have been associated with decreased lung function.1,2,20 Moreover,
schoolchildren with asthma and AHR have been found to have
lower vitamin D levels than their peers without AHR.3,4 In contrast,
in a recent report of schoolchildren with asthma, vitamin D levels
showed no correlation with AHR or lung function.5 These findingsTable 2
Correlations Among S-25-OHD, hs-CRP, and Other Continuous Baseline Data
Baseline measurements S-25-OHD (N ¼ 79) hs-CRP (N ¼ 61)
rs P value sB P value
Age 0.026 .819 0.103 .255
BMI 0.016 .886 0.009 .920
Total IgE 0.108 .343 0.088 .333
Blood eosinophil count 0.161 .157 0.083 .365
Blood eosinophil percentage 0.181 .110 0.053 .555
FRC z-score 0.109 .340 0.022 .811
V0max,FRC z-score 0.047 .679 0.073 .428
PD40 V0max,FRC 0.078 .495 0.080 .381
Abbreviations: BMI, body mass index; FRC, functional residual capacity; hs-CRP,
high-sensitivity C-reactive protein; IgE, immunoglobulin E; PD40 V0max,FRC, dose of
methacholine causing 40% decrease in maximal expiratory flow at functional
residual capacity; rs, Spearman rank correlation coefficient; S-25-OHD,
25-hydroxyvitamin D; V0max,FRC, maximal expiratory flow at functional residual
capacity; sB, Kendall s-b coefficient.
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strong and clear association between low vitamin D levels and
wheezing or decreased lung function. Interestingly, however, in our
study, the S-25-OHD levels were low in a subgroup of infants with
blood eosinophilia and AHR.
The childrenwith high prenatal maternal vitamin D intake had a
decreased risk of recurrent wheezing in early childhood.18 Simi-
larly, cord blood vitamin D was inversely associated with the risk of
respiratory infections at 3 months of age and with the risk of
wheezing from 15 months to 5 years of age.18
Animal studies have indicated that vitamin D stimulates type II
alveolar cell maturation and airway alveolarization,21 and therefore
vitamin D deficiency might alter the airway maturation and pre-
dispose to adverse respiratory outcomes. Moreover, vitamin D
might inhibit the postnatal inflammatory response and the
resulting epithelial injury during viral infections,1 the underlying
causes of early childhood wheeze. These findings support our
conclusion that vitamin D insufficiency might modify the airways
in symptomatic infants with blood eosinophilia and AHR.
Vitamin D insufficiency did not promote hs-CRPemediated low-
grade systemic inflammation. This is supported by previous find-
ings demonstrating that eosinophilic inflammation and remodeling
of the airways are rare during the first 2 years of life22 and that the
association between a thickening of bronchial reticular basement
membrane and eosinophilic bronchial inflammation appears later
in childhood.23 Because the children in our study were younger
than 3 years, the inflammatory process could still be subclinical,
explaining in part the low hs-CRP levels.
In contrast to our results, oral vitamin D supplementation as a
sole therapy for mild asthma has failed to affect AHR or allergic
inflammation.24 This might reflect the heterogeneity of asthma in
different age groups. Similarly, the heterogeneity of early childhood
respiratory symptoms could explain why in our study S-25-OHD
was significantly lower only in a subgroup of symptomatic infants
with blood eosinophilia and AHR, and no such difference emerged
when comparing all infants with AHR and those without it.
Although the final sample size was rather small, all patients
underwent comprehensive lung function tests with standardized
techniques. We also measured S-25-OHD from peripheral blood,
instead of relying on parental interviews or intake calculations, and
thus minimized the risk of reporting bias. The study patients were
recruited from a tertiary clinic and thus more often presented se-
vere symptoms, and the results cannot be generalized to the entire
population of early childhood wheezers. Moreover, the cross-
sectional study design did not allow an evaluation of the impor-
tance of our findings for the risk of developing asthma, an issue that
is to be resolved in future follow-up studies.
We conducted an observational pilot study to evaluate the
relation between vitamin D insufficiency and AHR to methacholine
in infants with troublesome lung symptoms. Because the normal
distribution of the variable PD40 V0max,FRC is not known in children
younger than 3 years, and the incidence of vitamin D insufficiency
defined as an S-25-OHD concentration lower than 50 nmol/L varies
greatly among different populations and age groups, we could not
reliably estimate statistical power before commencing the study.
Nevertheless, in post hoc analyses based on recent information on
vitamin D insufficiency and its relation to asthmatic symptoms in
children, the estimated power ranged from 28%5,25 to 79%.26,27
With a more stringent study participant selection based on
vitamin D insufficiency and degree of AHR, our results could have
been strengthened.
Larger cross-sectional studies are still required to fully elicit the
role of vitamin D insufficiency and AHR in infants with recurrent or
persistent lower airway symptoms. In future, randomized
controlled intervention studies with a long-term follow-up alsocould evaluate whether sufficient S-25-OHD levels acquired by oral
vitamin D supplementation might decrease the risk of future
asthma in early childhood wheezers.
In conclusion, vitamin D insufficiency might underlie eosino-
philia and AHR in infants with troublesome lung symptoms,
whereas hs-CRPemediated low-grade systemic inflammation is
rare in early childhood wheezing.
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